Chemed (CHE) Misses Q3 EPS by 3c, Offers Guidance
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $499.89 +0.66%
Revenue Growth %: +7.9%
Financial Fact:
Interest expense: -1.02M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +7.9%
Financial Fact:
Interest expense: -1.02M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Chemed (NYSE: CHE) reported Q3 EPS of $1.48, $0.03 worse than the analyst estimate of $1.51. Revenue for the quarter came in at $358.4 million versus the consensus estimate of $360 million.
Chemed sees FY2014 EPS of $6.00-$6.05, versus the consensus of $5.95.
For earnings history and earnings-related data on Chemed (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- AutoZone (AZO) PT Lowered to $4,230 at UBS Following 'Underwhelming' Q4 Print
- Top Wealth Group expects net profit to double in fiscal 2026
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
